Court blocks US gov's 340B Rebate Model Pilot Program, citing failure to meet admin law reqs. Hospital groups argued for ...

A recent analysis of the federal government’s 340B drug discount program suggests that program eligibility is too broad and that lawmakers need to tighten it, which may mean that hundreds of hospitals ...

Despite the rancor, there are many bipartisan opportunities for the divided 118 th Congress. Near the top of the to-do list should be reforming the well-intentioned, but poorly designed, 340B drug ...

The 340B Drug Pricing Program was developed more than three decades ago to help improve access to medicines for vulnerable patients 4 via manufacturer discounts to specific nonprofit hospitals and ...

The results indicate that the program could play a role in discouraging use of biosimilars in the United States. Hospitals participating in the 340B Drug Pricing Program had lower biosimilar uptake, ...

On May 28, representatives from three states introduced a federal bill to amend the 340B program by recognizing contract pharmacies, restricting pharmacy benefit managers and tightening eligibility ...

Hospitals are up in arms over new guidance issued by the Health Resources and Services Administration on Thursday that could restrict the eligibility of their outpatient clinics for drug discounts in ...

The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.

New research has found the 340B program is slowing uptake of biosimilars by incentivizing use of more expensive biologics. The 340B program has driven provider variation in the uptake of biosimilars ...

Too often Kansans hear the rotors of another air ambulance carrying a patient from a rural area to an urban health care facility to receive treatment. Like a beating drum, the sound reminds us of the ...